Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jun 23,2017
Skin Microbiome Can Be Negatively Altered by Topical Antibiotics
    Scientists at the Perelman School of Medicine at the University of Pennsylvania say the use of topical antibiotics can dramatically alter communities of bacteria that live on the skin, while the use of antiseptics has a much smaller, less durable impact. The study ("Topical antimicrobial treatments can elicit shifts to resident skin bacterial communities and reduce colonizationRead more
More
Skin Microbiome Can Be Negatively Altered by Topical Antibiotics
Jun 23,2017
Isolating Anti-Alzheimer’s Compounds in Plants
    Traditional plant medicines have been used by humans for a long time, and these therapies are still popular in many countries. Plants typically contain a huge variety of compounds, many of which have no effect in the body, and some which can have significant effects.  However isolating specific efficacious molecules from the milieu of compoundsRead more
More
Isolating Anti-Alzheimer’s Compounds in Plants
Jun 23,2017
The effectiveness and safety evaluation of traditional Chinese medicine injections
At the 28th meeting of the Standing Committee of the Twelfth National People's Congress held on June 22, the National People's Congress Deputies Committee heard and deliberated the State Council's report on drug administration. Commissioned by the State Council, Bi Jingquan, director of the State Food and Drug Administration, made a report. The report mentionedRead more
More
Jun 22,2017
New Immune System Finding May Open Door to Novel Cancer Therapies
    Most living cells have a defined number of chromosomes: Human cells, for example, have 23 pairs. As cells divide, they can make errors that lead to a gain or loss of chromosomes, which is usually very harmful.     Biologists at the Massachusetts Institute of Technology (MIT) say they have identified a mechanism that the immune systemRead more
More
Jun 22,2017
The First Vaccine to Lower Cholesterol
    It gives rise to antibodies that could prevent disease, but it's not quite a vaccine. It qualifies as an immunotherapy because it targets one of the body's own proteins, not a protein associated with a pathogen. The "it” in this case is AT04A, a peptide-based formulation that induces an immune response against a protein thatRead more
More
The First Vaccine to Lower Cholesterol
Jun 22,2017
Inventory of Common Developmental and Reproductive Toxicity (DART) Studies Animals Species
The reproductive toxicity test is divided into section I, section II, and section III reproductive toxicity test. Part I reproductive toxicity test: also known as general reproductive toxicity test. The drug is administered before the animal mating, and the purpose is to evaluate whether the germ cells have any adverse effects on the conception ability,Read more
More
Inventory of Common Developmental and Reproductive Toxicity (DART) Studies Animals Species
Jun 21,2017
Distant Brain Regions Selectively Recruit Stem Cells
    Long-distance connections in the adult brain may dial up stem-cell niches and order the delivery of particular types of neurons. Of all the brain's stem-cell niches, the largest is the ventricular–subventricular zone (V-SVZ), which supplies neurons to the olfactory bulb. While the olfactory bulb's densely interwoven network of neurons has been known to be importantRead more
More
Jun 21,2017
Discovery Could Guide Immunotherapy for Lung Cancer
    Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.  The group’s study (“Tissue-Resident Memory Features Are Linked to the Magnitude of Cytotoxic T Cell Responses in Human Lung Cancer”) appears in Nature Immunology.     Investigators at the University of Southampton and the LaRead more
More
Jun 21,2017
Adenovirus Construction Services
Techniques Introduction: Recombinant adenovirus is one of the most efficient and reliable recombinant viral expression systems available for transient expression of shRNA or target proteins in mammalian cells at instantaneously and high levels. There is no question that the adenovirus is the most effective means of delivering genes in vivo and in vitro. Construction ofRead more
More
Adenovirus Construction Services
Jun 20,2017
Newly Discovered Cellular Pathway May Lead to Cancer Therapies
    An international research team reports the discovery of a new cellular pathway that can promote and support the growth of cancer cells. In a mouse model of melanoma, blocking this pathway resulted in reduction of tumor growth.       The study ("Transcriptional Activation of RagD GTPase Controls mTORC1 and Promotes Cancer Growth”), which is published in Science, offersRead more
More
Newly Discovered Cellular Pathway May Lead to Cancer Therapies
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->